Beauty Health Co

For the period ended Dec 31, 2025. Filed Mar 12, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 12, 2026

SKIN$15.94-4.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Comprehensive Income (Loss

(in thousands, except for share and per share amounts)

	Year Ended December 31,
	2025	2024	2023
Net sales	$300,790	$334,294	$397,991
Cost of sales	104,426	151,998	242,878
Gross profit	196,364	182,296	155,113
Operating expenses:
Selling and marketing	93,590	118,311	144,496
Research and development	5,628	6,296	10,102
General and administrative	117,949	125,463	131,432
Total operating expenses	217,167	250,070	286,030
Loss from operations	(20,803)	(67,774)	(130,917)
Interest expense	19,326	10,412	13,649
Interest income	(8,954)	(16,644)	(23,173)
Other income, net	(18,931)	(33,563)	(5,200)
Change in fair value of warrant liabilities	(487)	(3,067)	(11,919)
Foreign currency transaction (gain) loss, net	(5,819)	4,638	(2,385)
Loss before provision for income taxes	(5,938)	(29,550)	(101,889)
Income tax expense (benefit)	3,581	(452)	(1,773)
Net loss	(9,519)	(29,098)	(100,116)
Comprehensive loss, net of tax:
Foreign currency translation adjustments	5,519	(3,917)	1,494
Comprehensive loss	$(4,000)	$(33,015)	$(98,622)
Net loss per share
Basic	$(0.08)	$(0.23)	$(0.76)
Diluted	$(0.16)	$(0.36)	$(0.76)
Weighted average common stock outstanding
Basic	126,378,509	123,827,372	131,680,605
Diluted	135,798,202	142,492,575	131,680,605

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.